[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353760-105":59,"doc-detail-353760-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinicopathological-and-prognostic-insights-into-embryonal-tumors-with-multilayered-rosettes-etmrs","Clinicopathological and prognostic insights into Embryonal Tumors with Multilayered Rosettes (ETMRs)","","Embryonal tumors with multilayered rosettes (ETMRs) are rare, highly aggressive pediatric brain neoplasms with early onset and poor outcomes. This retrospective study analyzes clinicopathological and molecular characteristics of ETMR cases diagnosed over 14 years at the National Cancer Institute, Cairo University, emphasizing diagnostic features, clinical presentation, and survival. A cohort of 35 patients was evaluated using pathology, Ki67, C19MC amplification, LIN28A expression, and survival statistics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathological-and-prognostic-insights-into-embryonal-tumors-with-multilayered-rosettes-etmrs/353760/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathological-and-prognostic-insights-into-embryonal-tumors-with-multilayered-rosettes-etmrs/353760.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What defines embryonal tumors with multilayered rosettes (ETMRs) in this study?","Question",{"text":112,"@type":113},"ETMRs are described as highly aggressive pediatric CNS tumors with characteristic histopathological features and a molecular hallmark involving amplification of the C19MC miRNA cluster, with LIN28A expression serving as an immunohistochemical surrogate.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were prognostic factors assessed for ETMR patients?",{"text":117,"@type":113},"The study used Kaplan-Meier survival curves and univariable Cox regression, correlating survival with surgical resection extent, adjuvant therapy, and pathological findings such as necrosis and mitotic activity.",{"name":119,"@type":110,"acceptedAnswer":120},"Which patient and pathological factors were associated with worse overall survival?",{"text":121,"@type":113},"Inferior survival was linked to incomplete surgical resection, absence of adjuvant therapy, and pathological presence of necrosis and a high mitotic index.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353760,1791630942,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Ebrahim etal. Diagnostic Pathology (2026) 21:24  \n[https://doi.org/10.1186/s13000-026-01766-y](https://doi.org/10.1186/s13000-026-01766-y)  \nDiagnostic Pathology  \nRESEARCH Open Access  \nClinicopathological and prognostic insights into Embryonal Tumors with Multilayered  \nRosettes (ETMRs)  \nNoura A. A. Ebrahim 1*, Heba A. Abdelbaky 1, Ahmed Mustafa Abd Elsalam2, Mustafa A Hussein1 and Nancy H Amin1  \nAbstract  \nBackground Embryonal tumors with multilayered rosettes (ETMRs) are rare, highly aggressive pediatric brain neoplasms characterized by early onset and dismal prognosis. This study presents a comprehensive  \nclinicopathological and molecular analysis of ETMR cases diagnosed over a 14-year period at National Cancer Institute, Cairo University, with a focus on diagnostic features, clinical presentation, and survival outcomes.  \nMethods A retrospective review of 35 patients with histopathologically confirmed ETMRs was conducted. Demographic data, clinical symptoms, neuroimaging findings, histopathologic features-including rosette formation, mitotic activity, necrosis, and Ki67 proliferation index-as well as molecular analyses for C19MC amplification and LIN28A expression were evaluated. Kaplan-Meier survival curves and univariable Cox regression were used to assess prognostic associations.  \nResults The cohort comprised 17 females and 18 males, with a median age of 36 months. Common presenting symptoms included signs of raised intracranial pressure, seizures, and motor deficits. Gross total resection was achieved in 43% of patients, and 48% received adjuvant chemoradiotherapy. Histopathologic examination consistently revealed ependymoblastic rosettes (true multilayered rosettes) and high mitotic activity. LIN28A was diffusely expressed in all assessable cases. Molecular confirmation by PCR testing was done in 20 cases. The median overall survival was 19 months. Factors associated with inferior survival included incomplete surgical resection, absence of adjuvant therapy, and presence of necrosis and high mitotic index.  \nConclusion ETMRs demonstrate consistent histological and immunohistochemical features that can guide diagnosis in resource-limited settings. Despite therapeutic advances, prognosis remains poor, underscoring the urgent need for novel therapeutic strategies. Molecular testing for C19MC amplification and LIN28A expression supports diagnostic confirmation and may hold future prognostic or therapeutic relevance.  \nKeywords ETMR, Pediatric brain tumors, C19MC amplification, LIN28A, Histopathology, Molecular diagnostics, Prognosis, Rosette formation, Mitotic index, Necrosis, Chemoradiotherapy  \n*Correspondence:  \nNoura A. A. Ebrahim  \n[npathologist@gmail.com](npathologist@gmail.com)  \n1Oncologic Pathology Department, National Cancer Institute (NCI) -Cairo University, Cairo, Egypt  \n2Pediatric Oncology Department, National Cancer Institute (NCI)-Cairo University, Cairo, Egypt  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nEbrahim et al. Diagnostic Pathology (2026) 21:24  \nIntroduction  \nEmbryonal tumors with","cbCaicxKzY4hMdWM","https://ap.wps.com/l/cbCaicxKzY4hMdWM","pdf",3700413,15,"English","# Abstract\n# Introduction\n## Classification and molecular hallmark\n## Therapeutic context and study rationale\n# Materials and methods\n## Ethical considerations","[{\"question\":\"What defines embryonal tumors with multilayered rosettes (ETMRs) in this study?\",\"answer\":\"ETMRs are described as highly aggressive pediatric CNS tumors with characteristic histopathological features and a molecular hallmark involving amplification of the C19MC miRNA cluster, with LIN28A expression serving as an immunohistochemical surrogate.\"},{\"question\":\"How were prognostic factors assessed for ETMR patients?\",\"answer\":\"The study used Kaplan-Meier survival curves and univariable Cox regression, correlating survival with surgical resection extent, adjuvant therapy, and pathological findings such as necrosis and mitotic activity.\"},{\"question\":\"Which patient and pathological factors were associated with worse overall survival?\",\"answer\":\"Inferior survival was linked to incomplete surgical resection, absence of adjuvant therapy, and pathological presence of necrosis and a high mitotic index.\"}]","Clinicopathological and prognostic insights into Embryonal Tumors with Multilayered Rosettes (ETMRs) | PDF",1790107091,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad7f29c6be007362ded5e76fc9273780.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55b05064ad113a25e0e66d62f147cef9.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf830431bd7ef4153a0fec0de351cf21.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfb04c1f66fbb7314b76fb6eb0fa36b8.webp",980,1306]